GCP · Blog

GCP Blog — Field notes from clinical research

April 2026 Edition

The Lead Story

The Lead
GCP8 min read

Clinical Trial Budget Management: Building Compliant, Efficient Budgets in the ICH E6(R3) Era

Managing clinical trial budgets requires careful balance between regulatory compliance, operational efficiency, and resource optimization. With the recent release of ICH E6(R3) Good Clinical Practice guidance in September 2025, sponsors now have updated frameworks for implementing risk-based quality management and cost-effective trial designs. Understanding these requirements is critical for building budgets that meet regulatory expectations while controlling costs.

Read the full piece

Recent dispatches

GCP

Clinical Trial Delays Cost Prevention: Reducing Timeline Risk Without Compromising Compliance

The average Phase III clinical trial costs between $11.5 million and $53 million.

Read
GCP

Clinical Trial Milestones: Navigating FDA and ICH Regulatory Checkpoints for Successful Trial Execution

Clinical trials represent one of the most complex undertakings in pharmaceutical development, requiring precise coordination of regulatory requirements, scientific protocols, and patient safety measures.

Read
GCP

Audit Trail Requirements FDA 21 CFR Part 11 Clinical Research: What Regulators Expect and Why It Matters

Every click, every edit, every deletion in your clinical trial system creates a digital footprint.

Read
GCP

Clinical Trial Management Guidelines: Applying FDA and ICH E6(R3) Standards for Modern, Risk-Based Trial Execution

The clinical trial landscape has undergone significant transformation in recent years, driven by technological advances, evolving regulatory expectations, and lessons learned from the COVID-19 pandemic.

Read
GCP

Clinical Trial Project Management Challenges: Overcoming Regulatory Complexity, Enrollment Barriers, and Operational Risk

Clinical trials require navigating complex regulatory frameworks while coordinating countless moving pieces across multiple sites, vendors, and stakeholders.

Read
GCP

Clinical Study Startup Checklist: FDA and ICH E6(R3) Requirements to Prevent Costly Trial Delays

Starting a clinical trial involves navigating complex regulatory requirements and establishing systems that protect participants while ensuring data integrity.

Read
GCP

GCP SOP Template Clinical Trial Documentation ICH E6(R3): Building Compliant, Risk-Based SOPs for Modern Trials

Setting up a clinical trial requires precise documentation that meets regulatory standards while supporting efficient operations.

Read
GCP

Clinical Trial Project Management Guidelines: ICH GCP and FDA Requirements

Managing a clinical trial involves coordinating multiple stakeholders, regulatory requirements, and operational complexities that can make or break a study's success.

Read
GCP

ICH E6(R3) GCP Guidelines for Clinical Trials

The clinical trials landscape just experienced its most significant regulatory update in nearly a decade.

Read

The archive

42 pieces

Clinical Trial Compliance GCP Regulatory Guidelines: How to Meet FDA and ICH E6(R3) Expectations Without Derailing Your Study

CTMS Clinical Trial Management System Regulatory Compliance: Meeting FDA and 21 CFR Part 11 Requirements with Confidence

Clinical Trial Closeout Procedures: Ensuring FDA and ICH E6(R3) Compliance While Protecting Long-Term Data Integrity

CTMS vs EDC: Key Differences for Clinical Trial Management Teams

ICH E6(R3) Clinical Trial Risk Management Framework

FDA Clinical Trial Phases I II III IV Regulatory Guidance

Clinical Trial Compliance: Navigating ICH E6(R3) GCP Requirements in a Risk-Based Regulatory Era

CTMS and EDC Comparison as Clinical Data Management Systems

Vendor Management Clinical Trials CRO Oversight: Meeting FDA Expectations While Maintaining Control and Accountability

Clinical Site Selection Feasibility Checklist: FDA and ICH E6(R3) Criteria to Prevent Delays and Compliance Risk

ICH E6(R3) GCP Guidelines FDA EMA Implementation

Site Initiation Visit Checklist

Clinical Project Management GCP Pharmaceutical Research Guidelines

Clinical Trial Vendor Management: CRO Oversight and FDA Guidance

Clinical Trial Risk Management ICH E6(R3) Framework

FDA 21 CFR Part 11 Audit Trail Requirements Compliance

Site Initiation Visit Checklist GCP FDA Guidance

Clinical Trial Phases Lifecycle FDA ICH E6 Guidance

Clinical Trial Sponsor Oversight Responsibilities

Clinical Trial Team Roles Responsibilities GCP Guidelines

ICH E6 GCP Guidelines for Clinical Trials

Clinical Trial Startup FDA ICH E6 GCP Requirements

FDA 21 CFR Part 11 Electronic Records Software Compliance Guidance

Investigator Initiated Trials IIT Management

The Importance of Good Clinical Practice in Real-World Evidence Studies

The Role of Ethics in Clinical Trials: A Deep Dive

Overcoming Common GCP Compliance Challenges in Clinical Research

The Role of Good Clinical Practice in Pediatric Clinical Trials

The Role of Technology in Streamlining GCP Compliance and Clinical Trial Management

Mastering GCP Compliance: Top Tips for Clinical Trial Sites

Risk-Based Monitoring in Good Clinical Practice: An Innovative Approach

How to Ensure Data Integrity in Clinical Research

Navigating Patient Rights and Safety in Clinical Studies

Understanding the Principles of GCP

Good Clinical Practice in the Era of Remote and Decentralized Clinical Trials

Introduction to ICH E6 Good Clinical Practice Guidelines

Breaking Down the Elements of Informed Consent

The Importance of Protocol Compliance in Clinical Trials

Essential Documents in Good Clinical Practice: A Comprehensive Guide

Establishing GCP Compliance in Clinical Research Organizations

The Evolution of Good Clinical Practice Guidelines A Historical Overview

Data Quality and Good Clinical Practice